A New Paradigm for the Management of Unresectable Hepatocellular Carcinoma

 

Cleveland Clinic Taussig Cancer Institute
S

Clinical Implications of the HIMALAYA Study: Safety & Efficacy of Durvalumab & Tremelimumab Regimen in 1L Unresectable HCC

By Cleveland Clinic Taussig Cancer Institute FEATURING Suneel Kamath
By Cleveland Clinic Taussig Cancer Institute FEATURING Suneel Kamath
458 views
July 20, 2023
0 Comments
Login to view comments. Click here to Login
A New Paradigm for the Management of Unresectable Hepatocellular Carcinoma
07:19
Cleveland Clinic Taussig Cancer Institute

Clinical Implications of the HIMALAYA Study: Safety & Efficacy o…

Feat. S. Kamath
09:16
Ahmed O. Kaseb

Current Unmet Needs in Advanced HCC

13:48
Yale Cancer Center

Considerations for 1L Treatment Selection in Advanced HCC: Safety an…

Feat. S. Stein
09:23
Johns Hopkins

Advancements in Systemic Therapy for Advanced HCC: Where Are We Going

Feat. M. Yarchoan
17:56
Insights from 2023 ESMO World Congress on Gastrointestinal Cancer Annual Meeting

How to Integrate and Sequence New Agents in Advanced HCC

Feat. L. Rimassa
14:14
Stanford Medicine

HCC: Updates in Management

Feat. R. Dhanasekaran
06:06
2023 Johns Hopkins Updates in Gastrointestinal Cancers

Very Large Solitary HCC: Resectable Disease Should Be Resected

Feat. C. Shubert
06:31
2023 Johns Hopkins Updates in Gastrointestinal Cancers

The Option of Radiation Therapy for HCC

Feat. J. Meyer
13:54
2023 Johns Hopkins Updates in Gastrointestinal Cancers

HCC and IO: Does Etiology Matter?

Feat. W. Jin Ho
22:08
Cedars Sinai

Approach to the Patient with a Liver Mass

Feat. W. Ayoub
28:30
2023 Johns Hopkins Updates in Gastrointestinal Cancers

Medical Oncology Updates in Unresectable HCC: Where Are We and Where…

Feat. D. Li
21:46
Rush University Medical Center

Hepatocellular Cancer Treatments

Feat. S. Eswaran
14:18
Ali Alqahtani

IO in Advanced Non-Viral HCC